Imidazoline ligand BU224 reverses cognitive deficits, reduces microgliosis and enhances synaptic connectivity in a mouse model of Alzheimer's disease-Reference-Cited by-同舟云学术

Imidazoline ligand BU224 reverses cognitive deficits, reduces microgliosis and enhances synaptic connectivity in a mouse model of Alzheimer's disease

Published:2020-12-27 Issue:3 Volume:178 Page:654-671
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Mirzaei Nazanin¹,Mota Bibiana C.¹,Birch Amy M.¹,Davis Nicola¹,Romero‐Molina Carmen¹,Katsouri Loukia¹,Palmer Emily O.C.¹,Golbano Arantxa²,Riggall Laura J.¹,Nagy Istvan³,Tyacke Robin¹,Nutt David J.¹,Sastre Magdalena¹

Affiliation:

1. Department of Brain Sciences Imperial College London, Hammersmith Hospital London UK

2. Institute of Neurosciences Universitat Autònoma de Barcelona Barcelona Spain

3. Department of Surgery and Cancer Imperial College London, Chelsea and Westminster Hospital London UK

Funder

Dunhill Medical Trust

Imperial College London

Edmond J. Safra Philanthropic Foundation

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15312

Reference63 articles.

1. Bicyclic α‐iminophosphonates as high affinity imidazoline I2 receptor ligands for Alzheimer's disease;Abás S.;Journal of Medicinal Chemistry,2020

2. LSL 60101, a selective ligand for imidazoline I2 receptors, on glial fibrillary acidic protein concentration

3. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes

4. The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors;Alexander S. P. H.;British Journal of Pharmacology,2019

5. The Concise Guide to PHARMACOLOGY 2019/20: Ion channels;Alexander S. P. H.;British Journal of Pharmacology,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imidazoline receptors as a new therapeutic target in Huntington’s disease: A preclinical overview;Ageing Research Reviews;2024-11

2. Comparative proteomic analysis of cerebral cortex revealed neuroprotective mechanism of esculentoside A on Alzheimer's disease;European Journal of Pharmacology;2024-02

3. Visualizing reactive astrocytes: Positron emission tomography imaging ligands for imidazoline‐2 binding sites;VIEW;2023-11-09

4. Ameliorative effects of bromelain on aluminum-induced Alzheimer's disease in rats through modulation of TXNIP pathway;International Journal of Biological Macromolecules;2023-02

5. Moxonidine ameliorates cardiac injury in rats with metabolic syndrome by regulating autophagy;Life Sciences;2023-01